Navigation Links
Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
Date:12/3/2008

s for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA immunotherapeutics for cancer, in which the expressed protein is an immune system stimulant; DNA vaccines for infectious diseases, in which the expressed protein is an immunogen; and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor. The company is developing certain infectious disease vaccines and cancer therapeutics internally. In addition, the company collaborates with major pharmaceutical companies and biotechnology companies that give it access to complementary technologies or greater resources. These strategic partnerships provide the company with mutually beneficial opportunities to expand its product pipeline and serve significant unmet medical needs. Additional information on Vical is available at www.vical.com.

This press release contains forward-looking statements subject to risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include statements about the EIP agreement, Allovectin-7(R), and the AIMM trial. Risks and uncertainties include: whether EIP will obtain the necessary regulatory approvals for the Turkish territory; whether EIP will successfully sell and market Allovectin-7(R) in Turkey and the Turkish Republic of Northern Cyprus; whether Vical will achieve any milestones and whether EIP will pay Vical any upfront or milestone payments under the agreement; whether Vical or others will continue development of Allovectin-7(R); whether Vical will be able to recruit patients into the AIMM trial as planned, if at all; whether Vical will receive all of the clinical trial funding from AnGes under the collaborative agreement; whether Allovectin-7(R) or any other product candidates will be shown to be safe and e
'/>"/>

SOURCE Vical Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
2. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
3. U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vicals Vaxfectin(R) Adjuvant
4. Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months
5. First Published Study of New HPV Test for Developing Countries Shows High Accuracy in Predicting Cervical Disease
6. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
7. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
8. Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data
9. Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
10. Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
11. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...e-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC ...ously approved reverse split of its common stock w... Nov. 9, 2009 on a 1-for-15 split-adjusted basis. ...er the new symbol OXBT. The stock also will have a...omes effective. ,, "This reverse split was over...
(Date:11/6/2009)...swire-FirstCall/ -- Watson Pharmaceuticals, Inc. (...ompany, announced today that Paul Bisaro, Watson,s...de an overview and update of the Company,s busines...erence on Wednesday, November 11, 2009 at 12:00 pm...ll be webcast live and can be accessed on Watson P...
(Date:11/6/2009)...ewswire-USNewswire/ -- The ,Help is Here Express, ...orgia throughout the week of November 9-13 at vari...lly-struggling patients access information on prog...or nearly free. With the nation,s unemployment rat...escription Assistance (PPA) bus tour is raising aw...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3AIRS High Impact Series Offers Quick Solutions for Busy Recruiters 59792 1AIRS High Impact Series Offers Quick Solutions for Busy Recruiters 59792 2AIRS High Impact Series Offers Quick Solutions for Busy Recruiters 59792 3Structured Cabling Solutions Provider ICC Announces Rewards Program for Installers and Contractors 59789 1Structured Cabling Solutions Provider ICC Announces Rewards Program for Installers and Contractors 59789 2Philips Launches DirectLife a New Personal Fitness Program to Help People Lead Healthier Lives 59786 1Philips Launches DirectLife a New Personal Fitness Program to Help People Lead Healthier Lives 59786 2Philips Launches DirectLife a New Personal Fitness Program to Help People Lead Healthier Lives 59786 3Philips Launches DirectLife a New Personal Fitness Program to Help People Lead Healthier Lives 59786 4
...-May 29, 2007 - Gilead,Sciences, Inc. (Nasdaq:GILD...I-007) study of aztreonam lysine for inhalation fo...) who have,pulmonary Pseudomonas aeruginosa (P. ae...nge at Day 28 from baseline in respiratory,symptom...e-Revised,(CFQ-R), a patient-reported outcome (PRO...
...ewswire-FirstCall/ -- Alexza,Pharmaceuticals, Inc....Annual American Headache Society Meeting the resul...ochlorperazine (AZ-001),for the acute treatment of...cacy and tolerability profile of AZ-001,(Staccato ...he",(Poster S-72), will be available for viewing a...
Other Medicine Technology:Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 2Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 3Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 4Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 5Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at,the American Headache Society Meeting 2
(Date:11/8/2009)..., 3D Global Solutions is ... program managing the proposal effort for ReSound ... VA Digital Hearing Aid contract. The award includ...the Department of Defense and other federal agenci...) November 8, 2009 -- 3D Global Solutions is pleas...
(Date:11/8/2009)..., A jury of 8 people in t...e County woman $2,300,000 in pain and suffering fo...enney, James Tallman and Alicia Nocera of Thomas E...behalf of the plaintiff, Vita Monestersky and agai... an emergency total abdominal hysterectomy at age ...
(Date:11/8/2009)..., Nation,s largest network of Hispanic healt...th care reform in 2009 ,, WASHINGTON, Nov. 7 /...of Representatives showed they have heard the voic...Health Care for America Act. Now the Senate must d...l health care reform," said Dr. Jane L. Delgado, P...
(Date:11/8/2009)..., Calls for Swift Passage of H.R. 3961 to Se.... 7 Statement Attributa... Medical Association. ,, (Logo: http://www.ne..."The AMA hails the passage of the House health ref...m for patients and physicians and calls for swift ...
(Date:11/8/2009)..., Health Care Vote Shows Who Sides With Work...BURG, Pa., Nov. 8 On th...e of Representatives for a good, balanced health c... its scoring of how our state,s U.S. representativ...r America Act. ,, The legislation, which passe...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2
... a New,Jersey-based developer, manufacturer and di...medies, an India-based API and finished,dosages de...inalization of,a joint venture partnership to deve...ic products, several of which have,already progres...
...perated" Drug Plan, WASHINGTON, Oct. 23 Older ad... option of choosing prescription drug,coverage thr...e consumer,exploitation that plagues the current M... "Seniors and taxpayers deserve the choice of a Me...
...Technology Standards Panel (HITSP) has identified ...lp to keep patient medical,information secure in a...help to assure that this information will only be ...f important steps to assure the interoperability o...
..., researchers suggest , , TUESDAY, Oct. 23...nited States have remained constant since 2000, wi...n screened for the virus that causes AIDS. , But l...thin the past year, making it tougher to contain t...
...mplementing Affordable Treatments for the.... 23 , WHAT: The upcoming episode of the Charlie...amental problems of health in the developing world...rts will explore the challenge of researching and ...
... in Routinely Performed ...Care(R) Corp.,(Nasdaq: ARTC ), a leader in develo... products, announced today at the North American S...ed to remove soft tissue -- including disc,materia...
Other Medicine News:Health News:Amneal Pharmaceuticals & Indoco Remedies Finalize Long Term Joint Venture Agreement to Develop and Market Generic Ophthalmic Pharmaceuticals 2Health News:Amneal Pharmaceuticals & Indoco Remedies Finalize Long Term Joint Venture Agreement to Develop and Market Generic Ophthalmic Pharmaceuticals 3Health News:Report: Medicare-Administered Drug Benefit Would be More Affordable, Comprehensive, Stable than Current Private Insurance-Run Drug Benefit 2Health News:Report: Medicare-Administered Drug Benefit Would be More Affordable, Comprehensive, Stable than Current Private Insurance-Run Drug Benefit 3Health News:HITSP Defines Overarching Set of Healthcare Security and Privacy Standards 2Health News:Many at Risk for HIV Not Being Tested 2Health News:Many at Risk for HIV Not Being Tested 3Health News:Charlie Rose Science Series Episode #10 - GLOBAL HEALTH October 29, 2007 2Health News:ArthroCare Releases New SpineWand(R) for Less Invasive Spinal Surgeries 2Health News:ArthroCare Releases New SpineWand(R) for Less Invasive Spinal Surgeries 3
STA NEOPLASTINE CI + 10 (ISI ~ 1.3)
STA NEOPLASTINE CI 5 (ISI ~ 1.8)
Creatinine (Liquid)
Total Protein (Liquid)
Medicine Products: